Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Cerus Corp (CERS)

Cerus Corp (CERS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 627,239
  • Shares Outstanding, K 140,322
  • Annual Sales, $ 76,050 K
  • Annual Income, $ -57,560 K
  • 60-Month Beta 1.60
  • Price/Sales 10.00
  • Price/Cash Flow N/A
  • Price/Book 10.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.10
  • Low Estimate -0.13
  • Prior Year -0.12
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.95 +10.63%
on 11/11/19
4.68 -6.62%
on 11/01/19
-0.10 (-2.24%)
since 10/18/19
3-Month
3.95 +10.63%
on 11/11/19
5.61 -22.10%
on 08/19/19
-1.11 (-20.26%)
since 08/16/19
52-Week
3.95 +10.63%
on 11/11/19
6.88 -36.48%
on 03/01/19
-0.91 (-17.23%)
since 11/16/18

Most Recent Stories

More News
Cerus Corporation to Present at the Stifel 2019 Healthcare Conference

Cerus Corporation (Nasdaq:CERS) announced today that Kevin D. Green, Cerus' chief financial officer, will present at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 2:25 p.m. ET...

CERS : 4.37 (-2.24%)
Cerus Corporation to Present at the Stephens Nashville Investment Conference

Cerus Corporation (Nasdaq:CERS) announced today that Kevin D. Green, Cerus' chief financial officer, will present at the Stephens Nashville Investment Conference on Wednesday, November 13, 2019 at 10:30...

CERS : 4.37 (-2.24%)
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates

Cerus (CERS) delivered earnings and revenue surprises of -18.18% and 2.76%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

CERS : 4.37 (-2.24%)
Cerus: 3Q Earnings Snapshot

CONCORD, Calif. (AP) _ Cerus Corp. (CERS) on Wednesday reported a loss of $18 million in its third quarter.

CERS : 4.37 (-2.24%)
Cerus Corporation Announces Third Quarter 2019 Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the third quarter ended September 30, 2019.

CERS : 4.37 (-2.24%)
Will Cerus (CERS) Report Negative Earnings Next Week? What You Should Know

Cerus (CERS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CERS : 4.37 (-2.24%)
Cerus Corporation to Release Third Quarter 2019 Results and to Discuss Recent FDA Guidance for Bacterial Safety of Platelets on October 30, 2019

Cerus Corporation (Nasdaq:CERS) announced today that its third quarter 2019 results will be released on Wednesday, October 30, 2019, after the close of the stock market. The Company will host a conference...

CERS : 4.37 (-2.24%)
Cerus Corporation Announces Schedule of Presentations at the 2019 AABB Annual Meeting

Cerus Corporation (Nasdaq:CERS) announced today its schedule of key events and presentations at the 2019 AABB Annual Meeting which is taking place in San Antonio, Texas on October 19th through October...

CERS : 4.37 (-2.24%)
Zika Vaccines Market 2019: by Company Profile, Deals Type, Funding, Clinical Trials Insight

helps in immunization and prevention against the diseases caused by Zika virus. Aedes mosquitoes are the source of this virus that belongs to genus Flavivirus. Blood transfusion and sexual contact can...

CERS : 4.37 (-2.24%)
GSK : 44.33 (+0.54%)
IMV.TO : 3.20 (-2.14%)
INO : 2.28 (-2.98%)
NLNK : 1.56 (+1.96%)
SmarTrend Watching for Potential Rebound in Shares of Cerus Corp After 2.33% Loss

Cerus Corp (NASDAQ:CERS) traded in a range yesterday that spanned from a low of $4.59 to a high of $4.80. Yesterday, the shares fell 2.3%, which took the trading range below the 3-day low of $4.61 on...

CERS : 4.37 (-2.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade CERS with:

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

2nd Resistance Point 4.56
1st Resistance Point 4.46
Last Price 4.37
1st Support Level 4.30
2nd Support Level 4.23

See More

52-Week High 6.88
Fibonacci 61.8% 5.76
Fibonacci 50% 5.41
Fibonacci 38.2% 5.07
Last Price 4.37
52-Week Low 3.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar